21 Oct. 2010
WILMINGTON, N.C. (October 21, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Andreas Tschirky, Ph.D., as leader of BioDuro. In this role, Dr. Tschirky will have responsibility for providing scientific and operational leadership and managing the growth of the Beijing-based drug discovery services company PPD acquired last year.
"With more than 18 years of experience, Dr. Tschirky is extremely skilled at building and leading successful teams," said Lee Babiss, Ph.D., executive vice president of global laboratory services. "He is frequently consulted by the Chinese government on new regulations to support development of China's biopharmaceutical industry, and Dr. Tschirky's expertise will be valuable as we continue to see strong demand for our discovery services."
Dr. Tschirky spent the past 11 years with Roche, most recently serving as general manager of its Research and Development (R&D) Center in China. He was responsible for establishing and operating the center, which is recognized as the country's first drug discovery center by a multinational pharmaceutical company. Dr. Tschirky also served as head of R&D of Roche in China and held leadership roles with Roche China, Roche Basel and other Roche research facilities.
Prior to joining Roche, Dr. Tschirky was assistant group leader of an interdisciplinary group of scientists at Paul-Scherrer Institute and later served as project leader for the establishment of the New Adler-Pharmacy at Buchs, St. Gallen in Switzerland.
Dr. Tschirky completed his pharmacy degree from the University of Basel in Basel, Switzerland; his doctorate in pharmacy from the Paul-Scherrer Institute in Zurich; and his master of business administration from the China European International Business School in Shanghai.